ADCT
ADC Therapeutics SA
NYSE · Healthcare · Biotechnology · CH
$1.05
−0.94%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+4.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 2, 2026 | Zaki Mohamed · officer: Chief Medical Officer | A-Award | 213,900 | $0.00 |
| Jul 2, 2026 | GRAHAM PETER J · officer: Chief Legal Officer | A-Award | 221,100 | $0.00 |
| Jul 2, 2026 | Carmona Jose · officer: Chief Financial Officer | A-Award | 203,700 | $0.00 |
| Jul 2, 2026 | MALLIK AMEET · director, officer: Chief Executive Officer | A-Award | 675,000 | $0.00 |
| Apr 2, 2026 | Redmile Group, LLC · 10 percent owner | Sale | 2,634,506 | $3.28 |
| Apr 2, 2026 | Redmile Group, LLC · 10 percent owner | Sale | 188,407 | $3.75 |
| Apr 2, 2026 | Redmile Group, LLC · 10 percent owner | Sale | 2,529,491 | $3.28 |
| Apr 2, 2026 | Redmile Group, LLC · 10 percent owner | Sale | 196,229 | $3.75 |
| Apr 2, 2026 | Redmile Group, LLC · 10 percent owner | Sale | 169,265 | $3.80 |
| Apr 2, 2026 | Redmile Group, LLC · 10 percent owner | Sale | 162,517 | $3.80 |
| Feb 18, 2026 | MALLIK AMEET · director, officer: Chief Executive Officer | F-InKind | 103,231 | $3.99 |
| Feb 18, 2026 | Kallebo Lisa Michelle · officer: Chief Accounting Officer | A-Award | 62,900 | $3.99 |
| Feb 18, 2026 | Kallebo Lisa Michelle · officer: Chief Accounting Officer | F-InKind | 5,433 | $3.99 |
| Feb 18, 2026 | Zaki Mohamed · officer: Chief Medical Officer | A-Award | 285,200 | $3.99 |
| Feb 18, 2026 | Zaki Mohamed · officer: Chief Medical Officer | F-InKind | 24,603 | $3.99 |
| Feb 18, 2026 | GRAHAM PETER J · officer: Chief Legal Officer | A-Award | 294,800 | $3.99 |
| Feb 18, 2026 | GRAHAM PETER J · officer: Chief Legal Officer | F-InKind | 33,294 | $3.99 |
| Feb 18, 2026 | Carmona Jose · officer: Chief Financial Officer | A-Award | 271,600 | $3.99 |
| Feb 18, 2026 | Carmona Jose · officer: Chief Financial Officer | F-InKind | 25,880 | $3.99 |
| Feb 18, 2026 | MALLIK AMEET · director, officer: Chief Executive Officer | A-Award | 900,000 | $3.99 |
| Dec 9, 2025 | MALLIK AMEET · director, officer: Chief Executive Officer | F-InKind | 233,146 | $3.29 |
| Dec 9, 2025 | Carmona Jose · officer: Chief Financial Officer | F-InKind | 53,236 | $3.29 |
| Dec 9, 2025 | GRAHAM PETER J · officer: Chief Legal Officer | F-InKind | 49,508 | $3.29 |
| Dec 9, 2025 | Kallebo Lisa Michelle · officer: Chief Accounting Officer | F-InKind | 7,140 | $3.29 |
| Dec 9, 2025 | Zaki Mohamed · officer: Chief Medical Officer | F-InKind | 41,068 | $3.29 |
| Oct 28, 2025 | Redmile Group, LLC · 10 percent owner | Purchase | 3,846,153 | $0.00 |
| Jun 17, 2025 | Sandor Victor · director | F-InKind | 12,600 | $3.58 |
| Jun 17, 2025 | Azelby Robert · director | F-InKind | 12,600 | $3.58 |
| Jun 17, 2025 | Monges Viviane · director | F-InKind | 2,584 | $3.58 |
| Jun 17, 2025 | Squarer Ron · director | F-InKind | 15,184 | $3.58 |
Institutional positioning
13F filings over the trailing two quarters
New 46Increased 93Reduced 62Sold out 30
| Filer | Action | Shares | Filed |
|---|---|---|---|
| REDMILE GROUP, LLC | Reduced | 15,470,502 | May 15, 2026 |
| Nantahala Capital Management, LLC | Increased | 12,326,184 | Aug 19, 2026 |
| Redmile Group, LLC | Reduced | 11,526,710 | Aug 14, 2026 |
| TCG CROSSOVER MANAGEMENT, LLC | Unchanged | 11,390,175 | May 15, 2026 |
| TCG Crossover Management, LLC | Unchanged | 11,390,175 | Aug 14, 2026 |
| PROSIGHT MANAGEMENT, LP | Reduced | 8,300,000 | May 15, 2026 |
| Prosight Management, LP | Reduced | 7,824,749 | Aug 14, 2026 |
| BlackRock, Inc. | Increased | 7,020,093 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 6,250,747 | May 13, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | Increased | 5,701,655 | May 15, 2026 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | Increased | 5,597,433 | May 15, 2026 |
| MORGAN STANLEY | Reduced | 3,812,582 | May 15, 2026 |
| Point72 Asset Management, L.P. | Increased | 3,675,544 | Aug 14, 2026 |
| POINT72 ASSET MANAGEMENT, L.P. | Reduced | 3,408,529 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 3,254,154 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 2, 2026